Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Icon (ICLR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCA) and Icon (ICLR) with bullish sentiments.
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
HCA Healthcare (HCA)
TD Cowen analyst Ryan Langston maintained a Buy rating on HCA Healthcare today and set a price target of $431.00. The company’s shares closed last Thursday at $384.75.
According to TipRanks.com, Langston is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCA Healthcare with a $488.17 average price target, which is a 25.9% upside from current levels. In a report issued on June 10, TipRanks – PerPlexity also upgraded the stock to Buy with a $408.00 price target.
See today’s best-performing stocks on TipRanks >>
Icon (ICLR)
Deutsche Bank analyst Justin Bowers maintained a Buy rating on Icon today and set a price target of $188.00. The company’s shares closed last Thursday at $161.84.
According to TipRanks.com, Bowers is a 1-star analyst with an average return of
Icon has an analyst consensus of Moderate Buy, with a price target consensus of $174.25, which is a 10.2% upside from current levels. In a report released today, RBC Capital also upgraded the stock to Buy with a $185.00 price target.
Read More on HCA:
Disclaimer & DisclosureReport an Issue
- HCA Healthcare price target lowered to $431 from $500 at TD Cowen
- HCA Healthcare Announces Upcoming Chief Clinical Officer Transition
- HCA Healthcare Chief Clinical Officer to step down
- The Week That Was, The Week Ahead: Macro and Markets, June 14
- HCA Healthcare price target lowered to $415 from $480 at BofA
